MDXG

$3.25-0.91%visit website

MIMEDX GROUP, INC.

Market Cap

$474M

Live price × SEC shares (Oct 22, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.20

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

1.6

TTM to Sep 2026 · revenue

P/B

2.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	118,095	58,991	64,362	62,283	303,731
Cost of revenue	19,055	17,368	19,981	12,581	68,985
Gross profit	99,040	41,623	44,381	49,702	234,746
Research & development	4,761	4,140	2,777	2,796	14,474
Selling, general & administrative	73,073	53,231	59,779	58,313	244,396
Operating income	21,077	(16,049)	(18,466)	(11,702)	(25,140)
Interest expense	405	402
Pretax income	21,795	(15,331)	(17,780)	(11,062)	(22,378)
Income tax	6,604	(4,471)	(2,940)	(2,379)	(3,186)
Net income	15,191	(10,860)	(14,840)	(8,683)	(19,192)
EPS (basic) ($)		(0.07)	(0.10)	(0.06)	(0.13)
EPS (diluted) ($)		(0.07)	(0.10)	(0.06)	(0.13)
Weighted avg. shares (basic)		148,446	147,796	145,865
Weighted avg. shares (diluted)		148,446	147,796	145,865

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 28, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 62 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 4:03 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Oct 16, 2026 accepted 9:01 AM ET	8.01Other events	Document SEC ↗
Aug 11, 2026 accepted 4:44 PM ET	8-K/A 1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Jul 29, 2026 accepted 4:08 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jul 29, 2026 accepted 4:03 PM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Jun 16, 2026 accepted 4:12 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
Apr 29, 2026 accepted 4:01 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Apr 16, 2026 accepted 8:04 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Feb 25, 2026 accepted 4:02 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 12, 2026 accepted 8:04 AM ET	7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

66%

W/W +23.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

MiMedx (MDXG) Stock Slips As Q3 Earnings Leave Profit Questions

Yahoo · 2026-10-30

MiMedx Group, Inc Stock 12‑Month Price Target Cut to $7, Implies 77% Upside

TradingView · 2026-10-29

MiMedx Group, Inc. (MDXG) stock price, news, quote and history

Yahoo Finance Singapore · 2026-10-29

MiMedx Group, Inc. Q3 2026 Earnings Call Summary

Yahoo · 2026-10-29

Mizuho cuts MiMedx stock price target on wound segment weakness

Investing.com · 2026-10-29

MiMedx Group (NasdaqCM:MDXG) Stock Forecast & Analyst Predictions

Simply Wall St · 2026-10-29

MiMedx (MDXG) Q3 2026 Earnings Call Transcript

Yahoo · 2026-10-29

What MiMedx Group (MDXG) Said on Its Q3 Earnings Call

Yahoo · 2026-10-29

MiMedx Group, Inc. (MDXG) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-29

MiMedx (MDXG) Secures $25M Licensing Deal Settling Patent Dispute

GuruFocus · 2026-10-28

MiMedx: Q3 Earnings Snapshot

Yahoo · 2026-10-28

MIMEDX Announces Third Quarter 2026 Operating & Financial Results

Yahoo · 2026-10-28

MIMEDX Announces $25 Million Patent License Agreement

Yahoo · 2026-10-28

MiMedx Group, Inc. (MDXG) Q3 2026 Earnings Call Transcript

SeekingAlpha · 2026-10-28

MiMedx Group Q3 2026 Earnings Call Transcript

Benzinga · 2026-10-28

Informational purposes only, not investment advice.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 4:03 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Oct 16, 2026 accepted 9:01 AM ET	8.01Other events	Document SEC ↗
Aug 11, 2026 accepted 4:44 PM ET	8-K/A 1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Jul 29, 2026 accepted 4:08 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jul 29, 2026 accepted 4:03 PM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Jun 16, 2026 accepted 4:12 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
Apr 29, 2026 accepted 4:01 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Apr 16, 2026 accepted 8:04 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Feb 25, 2026 accepted 4:02 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 12, 2026 accepted 8:04 AM ET	7.01Reg FD disclosure	Document SEC ↗

MDXG

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

MIMEDX GROUP, INC. (MDXG)

Factor Profile

Corporate Events (8-K)